SCHEMBL3465242

SCHEMBL3465242

COC(=O)C(c1ccccc1OC)n1cncc1CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.33
CYP11B2 P19099 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ABCB11 O95342 1/20 0.33
GABRA2 P47869 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CTSA P10619 1/20 0.32
BTN3A1 O00481 1/20 0.31
GLS O94925 1/20 0.31
KMT2A Q03164 2/20 0.31
HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3465184 0.83 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2CYP3A4GABRA1
SCHEMBL1037425 0.82 CYP19A1 (0.35) MAPK1KMT2A
SCHEMBL3465188 0.82 GABRA1 (0.36) CYP11B1CYP11B2CYP1A2CYP3A4GABRA1
SCHEMBL17894240 0.78 CYP11B2 (0.38) CYP11B1CYP11B2
SCHEMBL14562264 0.78 CYP11B2 (0.40) CYP11B1CYP11B2
SCHEMBL13160967 0.76 MAPK1 (0.41) CYP11B1CYP11B2CYP1A2CYP3A4GABRA1
SCHEMBL3465788 0.76 CYP11B2 (0.41) CYP11B1CYP11B2LMNACTSA
SCHEMBL3465245 0.75 KMT2A (0.46) CYP11B1CYP11B2ALDH1A1KMT2AMEN1
SCHEMBL1097004 0.71
SCHEMBL24977253 0.66 GLS (0.38) LMNASMN1; SMN2ALDH1A1BTN3A1GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240641-A1 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors PAPILLON JULIEN 2010-09-23 US disclosed
US-20100240641-A1 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors PAPILLON JULIEN 2010-09-23 US disclosed
EP-2029604-A2 ALDOSTERONE SYNTHASE AND/OR 11BETA-HYDROXYLASE INHIBITORS Novartis AG (CH) 2009-03-04 EP disclosed
WO-2007139992-A2 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS NOVARTIS AG (CH) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240641-A1 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors HSD11B1, HSD11B2, CYP11B1 CYP11B1 3/4885CYP11B2 4/4885CYP1A2 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.